Research in Dr. Xu's laboratory is focused on human cardiomyocytes derived from human pluripotent stem cells, which hold promise for cardiac cell therapy, disease modeling, drug discovery, and the study of developmental biology. They have been collaborating with investigators at Georgia Tech, Emory University, and Children’s Healthcare of Atlanta, establishing new technologies and disease models for stem cell and cardiovascular research.
Their research has been funded by the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Science Foundation, the Center for the Advancement of Science in Space, the American Heart Association, and the Health and Environmental Sciences Institute/U.S. Food and Drug Administration. Their spaceflight experiment was hailed as a significant step for next-generation space research by the International Space Station National Laboratory and featured by CNN, NASA, and Chemical & Engineering News.
